Dji136
Preclinical
NovartisDji136 is one of 2 therapeutic programs targeting Extensive Stage Small Cell Lung Cancer (ES-SCLC). It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
1 competitor in Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Dji136. EMBL-EBI & Wellcome Sanger Institute.
- [3]